litlas
Log inCreate account

John J. Crowley

Active 1981–2022

78
Papers
30,233
Citations
75
h-index
77
i10-index

Citations

Citations per year for John J. Crowley1948: 1 citations1983: 1 citations1984: 2 citations1985: 2 citations1986: 7 citations1987: 3 citations1988: 4 citations1989: 6 citations1990: 4 citations1991: 13 citations1992: 9 citations1993: 18 citations1994: 19 citations1995: 33 citations1996: 22 citations1997: 30 citations1998: 26 citations1999: 37 citations2000: 44 citations2001: 67 citations2002: 85 citations2003: 109 citations2004: 143 citations2005: 169 citations2006: 176 citations2007: 221 citations2008: 207 citations2009: 277 citations2010: 259 citations2011: 254 citations2012: 249 citations2013: 280 citations2014: 268 citations2015: 232 citations2016: 233 citations2017: 199 citations2018: 184 citations2019: 613 citations2020: 681 citations2021: 575 citations2022: 409 citations2023: 250 citations2024: 396 citations2025: 164 citations2026: 3 citations1949–1982: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,094 citing papers, 29% of this breakdownChina: 702 citing papers, 6.6% of this breakdownUnited Kingdom: 668 citing papers, 6.3% of this breakdownItaly: 578 citing papers, 5.4% of this breakdownGermany: 507 citing papers, 4.7% of this breakdownFrance: 478 citing papers, 4.5% of this breakdownCanada: 457 citing papers, 4.3% of this breakdownNetherlands: 376 citing papers, 3.5% of this breakdownSpain: 358 citing papers, 3.4% of this breakdownAustralia: 278 citing papers, 2.6% of this breakdownJapan: 258 citing papers, 2.4% of this breakdownBelgium: 193 citing papers, 1.8% of this breakdown
0%29%Other 25.5%

Institutions

Fields

  • Medicine68.4%
  • Biochemistry, Genetics and Molecular Biology17.5%
  • Nursing6%
  • Agricultural and Biological Sciences1.9%
  • Immunology and Microbiology1.1%
  • Chemistry0.7%
  • Other4.4%

Topics

  • Lung Cancer Treatments and Mutations4.2%
  • Lung Cancer Diagnosis and Treatment4.1%
  • Multiple Myeloma Research and Treatments3.8%
  • Lung Cancer Research Studies3.1%
  • Prostate Cancer Treatment and Research2.7%
  • Prostate Cancer Diagnosis and Treatment2.7%
  • Other79.4%

Coauthors

All papers

Open in search
  1. Vitamin E and the Risk of Prostate Cancer

    Authors: Eric A. Klein, Ian M. Thompson, Catherine M. Tangen, John J. Crowley, M. Scott Lucia, Phyllis J. Goodman, Lori M. Minasian, Leslie G. Ford, Howard L. Parnes, J. Michael Gaziano, Daniel D. Karp, Michael M. Lieber, Philip Walther, Laurence Klotz, J. Kellogg Parsons, Joseph L. Chin, Amy K. Darke, Scott M. Lippman, Gary E. Goodman, Frank L. Meyskens, Laurence H. Baker - JAMA 2011 cited by 1,738

  2. International Staging System for Multiple Myeloma

    Authors: Philip R. Greipp, Jesús F. San Miguel, Brian G.M. Durie, John J. Crowley, Bart Barlogie, Joan Bladé, Mario Boccadoro, J. A. Child, Hervé Avet‐Loiseau, Robert A. Kyle, Juan José Lahuerta, Heinz Ludwig, Gareth J. Morgan, Raymond Powles, Kazuyuki Shimizu, Chaim Shustik, Pieter Sonneveld, Patrizia Tosi, Ingemar Turesson, Jan Westin - Journal of Clinical Oncology 2005 cited by 2,918

  3. Effect of Selenium and Vitamin E on Risk of Prostate Cancer and Other Cancers

    Authors: Scott M. Lippman, Eric A. Klein, Phyllis J. Goodman, M. Scott Lucia, Ian M. Thompson, Leslie G. Ford, Howard L. Parnes, Lori M. Minasian, J. Michael Gaziano, Jo Ann Hartline, J. Kellogg Parsons, James D. Bearden, E. David Crawford, Gary E. Goodman, Jaime O. Claudio, Eric Winquist, Elise D. Cook, Daniel D. Karp, Philip Walther, Michael M. Lieber, Alan R. Kristal, Amy K. Darke, Kathryn B. Arnold, Peter Ganz, Regina M. Santella, Demetrius Albanes, Philip R. Taylor, Jeffrey L. Probstfield, T. J. Jagpal, John J. Crowley, Frank L. Meyskens, Laurence H. Baker, Charles A. Coltman - JAMA 2008 cited by 2,115

  4. Prevalence of Prostate Cancer among Men with a Prostate-Specific Antigen Level ≤4.0 ng per Milliliter

    Authors: Ian M. Thompson, Donna K. Pauler, Phyllis J. Goodman, Catherine M. Tangen, M. Scott Lucia, Howard L. Parnes, Lori M. Minasian, Leslie G. Ford, Scott M. Lippman, E. David Crawford, John J. Crowley, Charles A. Coltman - New England Journal of Medicine 2004 cited by 2,433

  5. The IASLC Lung Cancer Staging Project: External Validation of the Revision of the TNM Stage Groupings in the Eighth Edition of the TNM Classification of Lung Cancer

    Authors: Kari Chansky, Frank Detterbeck, Andrew G. Nicholson, Valerie W. Rusch, Eric Vallières, Patti A. Groome, Catherine J. Kennedy, Mark Krasnik, Michael Peake, Lynn Shemanski, Vanessa Bolejack, John J. Crowley, Hisao Asamura, Ramón Rami–Porta, Peter Goldstraw, Ramón Rami–Porta, Hisao Asamura, David Ball, David G. Beer, Ricardo Beyruti, Vanessa Bolejack, Kari Chansky, John Crowley, Frank Detterbeck, Wilfried Eberhardt, John Edwards, Françoise Galateau-Sallé, Dorothy J. Giroux, Fergus Gleeson, Patti A. Groome, James Huang, Catherine J. Kennedy, Jhingook Kim, Young Tae Kim, Laura Kingsbury, Haruhiko Kondo, Mark Krasnik, Kaoru Kubota, Antoon Lerut, Gustavo Lyons, Mirella Marino, Edith M. Marom, Jan P. van Meerbeeck, Alan Mitchell, Takashi Nakano, Andrew G. Nicholson, Anna K. Nowak, Michael Peake, Thomas W. Rice, Kenneth E. Rosenzweig, Enrico Ruffini, Valerie W. Rusch, Nagahiro Saijo, Paul Van Schil, Jean‐Paul Sculier, Lynn Shemanski, Kelly Stratton, Kenji Suzuki, Yuji Tachimori, Charles F. Thomas, William D. Travis, Ming‐Sound Tsao, Andrew T. Turrisi, Johan Vansteenkiste, Hirokazu Watanabe, Yi‐Long Wu, Paul Baas, Jeremy Erasmus, Seiki Hasegawa, Kouki Inai, Kemp H. Kernstine, Hedy L. Kindler, Lee M. Krug, Kristiaan Nackaerts, Harvey I. Pass, David C. Rice, Conrad Falkson, Pier Luigi Filosso, Giuseppe Giaccone, Kazuya Kondo, Marco Lucchi, Meinoshin Okumura, Eugene H. Blackstone, F. Abad Cavaco, Emilio Ansótegui Barrera, J. Abal Arca, Isaura Parente Lamelas, A. Arnau Obrer, R. Guijarro Jorge, David Ball, G.K. Bascom, Ana Isabel Blanco Orozco, M. A. González Castro, Matthew G. Blum, Domingo Chimondeguy, Vlado Cvijanović, Sebastián Defranchi, B. de Olaiz Navarro, I. Escobar Campuzano, I. Macía Vidueira and 56 more - Journal of Thoracic Oncology 2017 cited by 507

  6. Meta-analysis of genome-wide association studies for cattle stature identifies common genes that regulate body size in mammals

    Authors: A.C. Bouwman, Hans D. Daetwyler, Amanda J. Chamberlain, Carla Hurtado Ponce, Mehdi Sargolzaei, Flávio S. Schenkel, Goutam Sahana, Armelle Govignon-Gion, Simon Boitard, Marlies Dolezal, Hubert Pausch, Rasmus Froberg Brøndum, Phil Bowman, Bo Thomsen, Bernt Guldbrandtsen, Mogens Sandø Lund, Bertrand Servin, Dorian J. Garrick, James M. Reecy, Johanna Vilkki, A. Bagnato, Min Wang, Jesse L. Hoff, Robert D. Schnabel, Jeremy F. Taylor, Anna A. E. Vinkhuyzen, Frank Panitz, Christian Bendixen, Lars‐Erik Holm, Birgit Gredler, Chris Hozé, Mekki Boussaha, Marie-Pierre Sanchez, Dominique Rocha, Aurélien Capitan, Thierry Tribout, Anne Barbat, Pascal Croiseau, Cord Drögemüller, Vidhya Jagannathan, Christy Vander Jagt, John J. Crowley, Anna Bieber, Deirdre C. Purfield, D.P. Berry, Reiner Emmerling, Kay‐Uwe Götz, Mirjam Frischknecht, Ingolf Ruß, Johann Sölkner, Curtis P. Van Tassell, Ruedi Fries, Paul Stothard, R.F. Veerkamp, Didier Boichard, Mike E. Goddard, Ben J. Hayes - Nature Genetics 2018 cited by 467

  7. Underrepresentation of Patients 65 Years of Age or Older in Cancer-Treatment Trials

    Authors: Laura F. Hutchins, Joseph M. Unger, John J. Crowley, Charles A. Coltman, Kathy S. Albain - New England Journal of Medicine 1999 cited by 2,192

  8. The Influence of Finasteride on the Development of Prostate Cancer

    Authors: Ian M. Thompson, Phyllis J. Goodman, Catherine M. Tangen, M. Scott Lucia, Gary J. Miller, Leslie G. Ford, Michael M. Lieber, R. Duane Cespedes, James N. Atkins, Scott M. Lippman, Susie M. Carlin, Anne Ryan, Connie M. Szczepanek, John J. Crowley, Charles A. Coltman - New England Journal of Medicine 2003 cited by 2,509

  9. Patient Income Level and Cancer Clinical Trial Participation

    Authors: Joseph M. Unger, Dawn L. Hershman, Kathy S. Albain, Carol M. Moinpour, Judith Petersen, Kenda Burg, John J. Crowley - Journal of Clinical Oncology 2013 cited by 287

  10. CELL BIOLOGY SYMPOSIUM: Genetics of feed efficiency in dairy and beef cattle1

    Authors: D.P. Berry, John J. Crowley - Journal of Animal Science 2013 cited by 365

  11. The International Association for the Study of Lung Cancer Staging Project: Prognostic Factors and Pathologic TNM Stage in Surgically Managed Non-small Cell Lung Cancer

    Authors: Kari Chansky, J.P. Sculier, John J. Crowley, Dori Giroux, Jan P. van Meerbeeck, Peter Goldstraw - Journal of Thoracic Oncology 2009 cited by 445

  12. Racial Disparities in Cancer Survival Among Randomized Clinical Trials Patients of the Southwest Oncology Group

    Authors: Kathy S. Albain, Joseph M. Unger, John J. Crowley, Charles A. Coltman, Dawn L. Hershman - JNCI Journal of the National Cancer Institute 2009 cited by 460

  13. Adult and Pediatric Antibiotic Prophylaxis during Vascular and IR Procedures: A Society of Interventional Radiology Practice Parameter Update Endorsed by the Cardiovascular and Interventional Radiological Society of Europe and the Canadian Association for Interventional Radiology

    Authors: Monzer Chehab, Avnesh S. Thakor, Sheryl Tulin‐Silver, Bairbre Connolly, Anne Marie Cahill, Thomas J. Ward, Siddharth A. Padia, Maureen P. Kohi, Mehran Midia, Gulraiz Chaudry, Joseph J. Gemmete, Jason Mitchell, Lynn A. Brody, John J. Crowley, Manraj K.S. Heran, Jeffrey L. Weinstein, Boris Nikolic, Sean R. Dariushnia, Alda L. Tam, Aradhana M. Venkatesan - Journal of Vascular and Interventional Radiology 2018 cited by 185

  14. Phase III Trial of Maintenance Gefitinib or Placebo After Concurrent Chemoradiotherapy and Docetaxel Consolidation in Inoperable Stage III Non–Small-Cell Lung Cancer: SWOG S0023

    Authors: Karen Kelly, Kari Chansky, Laurie E. Gaspar, Kathy S. Albain, James R. Jett, Yee Ung, Derick Lau, John J. Crowley, David R. Gandara - Journal of Clinical Oncology 2008 cited by 573

  15. Phase III Randomized, Intergroup Trial Assessing Imatinib Mesylate At Two Dose Levels in Patients With Unresectable or Metastatic Gastrointestinal Stromal Tumors Expressing the Kit Receptor Tyrosine Kinase: S0033

    Authors: Charles D. Blanke, Cathryn Rankin, George D. Demetri, Christopher W. Ryan, Margaret von Mehren, Robert S. Benjamin, A. Kevin Raymond, Vivien Bramwell, Laurence H. Baker, Robert G. Maki, Michael Tanaka, J. Randolph Hecht, Michael C. Heinrich, Christopher D.�M. Fletcher, John J. Crowley, Ernest C. Borden - Journal of Clinical Oncology 2008 cited by 1,077

  16. Surgery With or Without Preoperative Paclitaxel and Carboplatin in Early-Stage Non–Small-Cell Lung Cancer: Southwest Oncology Group Trial S9900, an Intergroup, Randomized, Phase III Trial

    Authors: Katherine M.W. Pisters, Eric Vallières, John J. Crowley, Wilbur A. Franklin, Paul A. Bunn, Robert J. Ginsberg, Joe B. Putnam, Kari Chansky, David R. Gandara - Journal of Clinical Oncology 2010 cited by 246

  17. Cure Models as a Useful Statistical Tool for Analyzing Survival

    Authors: Megan Othus, Bart Barlogie, Michael LeBlanc, John J. Crowley - Clinical Cancer Research 2012 cited by 213

  18. Prospective analysis of antigen-specific immunity, stem-cell antigens, and immune checkpoints in monoclonal gammopathy

    Authors: Madhav V. Dhodapkar, Rachael Sexton, Rituparna Das, Kavita M. Dhodapkar, Lin Zhang, Ranjini K. Sundaram, Sonal Soni, John J. Crowley, Robert Z. Orlowski, Bart Barlogie - Blood 2015 cited by 124

  19. Overview: Progression-Free Survival as an Endpoint in Clinical Trials with Solid Tumors

    Authors: Ronald L. Korn, John J. Crowley - Clinical Cancer Research 2013 cited by 84

  20. Concurrent Cisplatin, Etoposide, and Chest Radiotherapy in Pathologic Stage IIIB Non–Small-Cell Lung Cancer: A Southwest Oncology Group Phase II Study, SWOG 9019

    Authors: Kathy S. Albain, John J. Crowley, Andrew T. Turrisi, David R. Gandara, William B. Farrar, Joseph I. Clark, Kristie R. Beasley, Robert B. Livingston - Journal of Clinical Oncology 2002 cited by 345

  21. PGG-Glucan, a soluble β-(1,3)-glucan, enhances the oxidative burst response, microbicidal activity, and activates an NF-κB-like factor in human PMN: Evidence for a glycosphingolipid β-(1,3)-glucan receptor

    Authors: Eric Wakshull, Deborah Brunke-Reese, Johanna Lindermuth, Leslie Fisette, Robin Nathans, John J. Crowley, Jeffrey C. Tufts, Janet W. Zimmerman, William M. Mackin, David S. Adams - Immunopharmacology 1999 cited by 164

  22. A phase 2 trial of R1507, a monoclonal antibody to the insulin‐like growth factor‐1 receptor (IGF‐1R), in patients with recurrent or refractory rhabdomyosarcoma, osteosarcoma, synovial sarcoma, and other soft tissue sarcomas: Results of a Sarcoma Alliance for Research Through Collaboration study

    Authors: Alberto S. Pappo, Gilles Vassal, John J. Crowley, Vanessa Bolejack, Pancras C.W. Hogendoorn, Rashmi Chugh, Marc Ladanyi, Joseph F. Grippo, Georgina Dall, Arthur P. Staddon, Sant P. Chawla, Robert G. Maki, Dejka M. Araujo, Birgit Geoerger, Kristen N. Ganjoo, Neyssa Marina, Jean‐Yves Blay, Scott M. Schuetze, Warren Chow, Lee J. Helman - Cancer 2014 cited by 197

  23. Survival determinants in extensive-stage non-small-cell lung cancer: the Southwest Oncology Group experience.

    Authors: Kathy S. Albain, John J. Crowley, Michael LeBlanc, Robert B. Livingston - Journal of Clinical Oncology 1991 cited by 736

  24. Designing the Selenium and Vitamin E Cancer Prevention Trial (SELECT)

    Authors: Scott M. Lippman, Phyllis J. Goodman, Eric A. Klein, Howard L. Parnes, Ian M. Thompson, Alan R. Kristal, Regina M. Santella, Jeffrey L. Probstfield, Carol M. Moinpour, Demetrius Albanes, Philip R. Taylor, Lori M. Minasian, Ashraful Hoque, Sarah Thomas, John J. Crowley, J. Michael Gaziano, Janet L. Stanford, Elise D. Cook, Neil Fleshner, Michael M. Lieber, Philip Walther, Fadlo R. Khuri, Daniel D. Karp, Gary G. Schwartz, Leslie G. Ford, Charles A. Coltman - JNCI Journal of the National Cancer Institute 2005 cited by 356